Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRC59 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | STX5 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | DNAH10OS | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | ARID4B | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | SFR1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | SAR1A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | ARL1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | TAF1B | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | MYL6 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | VGF | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |